Peptides are legal in the US under specific conditions. A physician explains the FDA's 503A framework, which peptides are permitted, and which are not.
Routine bloodwork misses alcohol's metabolic toll. Learn which biomarkers reveal liver stress, hormonal disruption, and insulin resistance early, in this primer.
Nearly half of patients stop GLP-1 weight-loss drugs within a year. This primer explains why dropout happens and how structured, personalized care can improve adherence and outcomes.
GLP-1 receptor agonists reduce food cravings by reshaping brain reward signals, not by demanding willpower. This primer explains the neurobiology behind the quiet that patients describe.
A 2026 meta-analysis found a 3.5% biochemical recurrence rate in hypogonadal men on TRT after radical prostatectomy. This primer explains what that means for patients.
Fasting insulin detects insulin resistance years before glucose or HbA1c flag anything abnormal. Learn what it measures, how to interpret it, and why it belongs on your next lab panel.
Elevated homocysteine is linked to faster brain aging, but it is measurable and correctable. This primer covers MTHFR variants, B12 status, and methylated B vitamins.
Semaglutide slows digestion, quiets hunger signals in the brain, and improves insulin release. Learn how GLP-1 and dual GIP/GLP-1 medications work at the biological level.
Nausea, constipation, red-flag warnings, and titration strategies for semaglutide, evidence-grounded guidance for patients and clinicians.
Start with your $49 lab panel — know your numbers and take the first step toward peak performance.
Order $49 Labs